Sourcing and Management by Pharmaceutical Technology
July 2012 Volume 8 Issue 7

-----

Welcome to the July 2012 issue of Pharmaceutical Technology Sourcing and Management, Pharmaceutical Technology’s and Pharmaceutical Technology Europe’s information resource on pharmaceutical ingredients, manufacturing, and the supply chain. In this issue, we examine the strengths and weaknesses of the biosimilars market. Plus a special retrospective and prospective analysis of pharmaceutical manufacturing, market positioning, and pharmaceutical outsourcing.  And the latest developments from the bio/pharmaceutical industry relating to corporate social responsibility and sustainability.

Biologics
Biosimilars: Market Weaknesses and Strengths
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Biosimilars represent an emerging niche in the biopharmaceutical market, but how strong is their true potential? >> Read More

Outsourcing
Biomanufacturing Innovation
Eric Langer, president of BioPlan Associates
Industry wants more innovation, but can suppliers meet customer needs?
>> Read More

Global Feature
As part of  Pharmaceutical Technology’s special 35th Anniversary issue, we examine decades of change for the top pharmaceutical companies,  project the pharmaceutical company of 2020, delve into the future of chemical API manufacturing, and take a retrospective and prospective look at  pharmaceutical outsourcing.

Decades of Change for the Top Pharmaceutical Companies
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Tracking change from spinoffs of chemical companies to life-sciences powerhouses.
>> Read More

A Look into the Future: The Pharmaceutical Company of 2020
A Q&A with Carolyn Gauntlett, consultant with IMS Health
How will the pharmaceutical company of 2020 be different from the pharmaceutical company of 2010? A look at emerging business models and the factors influencing the direction of the global pharmaceutical industry.
>> Read More

What's Ahead in Chemical API Manufacturing
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Flow chemistry and microreactors offer an alternative to traditional batch manufacturing.
>> Read More

New Models in Contract Services
An industry roundtable examining how sponsor companies' increasing focus on strategic outsourcing has changed the rules of the game.
>> Read More

-----

CSR and Sustainability Forum
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations. >> Read More

The UN at the Sustainability Table
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management .
Highlights of UN Conference on Sustainable Development, held in Rio de Janeiro, Brazil, last month and related industry initiatives. >> Read More

-----

For the full listing of calendar events, see the Calendar of Events page

July
July 24–25
Bio/Pharmaceutical Manufacturing Outsourcing
Philadelphia

September
Sept. 10–13
Pharma ChemOutsourcing
Long Branch, NJ

October
Oct. 9–12
CPhI Worldwide
Madrid